Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niaspan and Endothelial Function in Coronary Atherosclerosis
NCT00150722Phase 3Completed
- Sponsor
- University of Calgary
- Start
- Sep 2005
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of niacin in coronary artery disease (CAD), sponsored by University of Calgary. Started Sep 2005; status: completed.
02
Drugs
niacin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00150722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150722.